ConductScience.org, home

Paper2201316

Tat and Rev: positive regulators of HIV gene expression.

Rosen CA and 1 other. AIDS, 1990. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Tat and Rev: positive regulators of HIV gene expression. Papers, record 2201316. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2201316

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tat and Rev: positive regulators of HIV gene expression.
PubMed
Journal
AIDS
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
2.19
iCite
Revised in PubMed
2007-11-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosen CAC A
2Pavlakis GNG N

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, ViralMajor topic
Gene Products, revMajor topic
Gene Products, tatMajor topic
HIVMajor topic
Trans-ActivatorsMajor topic
Amino Acid Sequence
Base Sequence
Humans
Molecular Sequence Data
rev Gene Products, Human Immunodeficiency Virus
tat Gene Products, Human Immunodeficiency Virus

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N01-CO-74101NCI NIH HHSUnited StatesN01CO074101PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in2285434Tat and Rev: positive regulators of HIV gene expression.https://conductscience.org/library/papers/2285434

Source PubMed

Download CSV of comments and corrections

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
37240414Complex Formation of an RNA Aptamer with a Part of HIV-1 Tat through Induction of Base Triples in Living Human Cells Proven by In-Cell NMR.Int J Mol Sci2023https://conductscience.org/library/papers/37240414PubMed
29793958SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.J Virol2018https://conductscience.org/library/papers/29793958PubMed
24287493Aptamer-based therapeutics: new approaches to combat human viral diseases.Pharmaceuticals (Basel)2013https://conductscience.org/library/papers/24287493PubMed
19886840Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia.AIDS Res Hum Retroviruses2009https://conductscience.org/library/papers/19886840PubMed
18431440Using an emissive uridine analogue for assembling fluorescent HIV-1 TAR constructs.Tetrahedron2007https://conductscience.org/library/papers/18431440PubMed
17319662Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery.J Am Chem Soc2007https://conductscience.org/library/papers/17319662PubMed
9611232TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer.Nucleic Acids Res1998https://conductscience.org/library/papers/9611232PubMed
9177178Casein kinase II is a selective target of HIV-1 transcriptional inhibitors.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9177178PubMed
8474155Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.J Virol1993https://conductscience.org/library/papers/8474155PubMed
8445733The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent.J Virol1993https://conductscience.org/library/papers/8445733PubMed
8445708The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat.J Virol1993https://conductscience.org/library/papers/8445708PubMed
8441609Rotational symmetry in ribonucleotide strand requirements for binding of HIV-1 Tat protein to TAR RNA.Nucleic Acids Res1993https://conductscience.org/library/papers/8441609PubMed
8350414Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.J Virol1993https://conductscience.org/library/papers/8350414PubMed
8189522Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.J Virol1994https://conductscience.org/library/papers/8189522PubMed
8151782Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm.J Virol1994https://conductscience.org/library/papers/8151782PubMed
8139007Human immunodeficiency virus type 1 Rev-responsive element RNA binds to host cell-specific proteins.J Virol1994https://conductscience.org/library/papers/8139007PubMed
7984424Rev of human immunodeficiency virus and Rex of the human T-cell leukemia virus type I can counteract an mRNA downregulatory element of the transferrin receptor mRNA.Nucleic Acids Res1994https://conductscience.org/library/papers/7984424PubMed
7983704Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K.J Virol1995https://conductscience.org/library/papers/7983704PubMed
7966618Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.J Virol1994https://conductscience.org/library/papers/7966618PubMed
7966585
Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.
J Virol1994https://conductscience.org/library/papers/7966585PubMed

See all 52 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TAT6898PubTator's text mininghttps://conductscience.org/library/genes/6898

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2201316

GET https://conductscience.org/api/papers/v1/2201316/cited_by?page=2